Abstract
Critical illness polyneuropathy (CIP) occurs in association with sepsis and multiple organ failure; however, little is known about the pathomechanisms of CIP and its therapy. In order to determine the parameters which interfere with development of CIP, electrophysiological investigations of peripheral nerves and biochemical measures were correlated to each other. The present study includes 20 consecutive patients in an intensive care unit developing severe sepsis or septic shock. Nerve conduction studies and electromyography were performed with occurring sepsis (day 1, 7, 14) and neurophysiological parameters were correlated with biochemical measures, especially indicators of infection and inflammation.
It was found that all patients developed neurophysiological signs of axonal motor polyneuropathy. There was a significant correlation between serum concentrations of endotoxin and interleukin-2 receptors (IL2-R) and reduction of the amplitude of the compound motor action potentials. Other clinical and biochemical parameters showed no significant correlations with neurophysiological data.
This finding apparently indicates that endotoxin damages nerve axons directly or indirectly, e.g. by activation of inflammatory cascades (IL2-R). Endotoxin appears to be an essential factor in the pathogenesis of CIP in sepsis, and therapeutic options neutralizing endotoxin may prevent development of CIP.
Similar content being viewed by others
References
Bannerman DD, Goldblum SE (1999) Direct effects of endotoxin on the endothelium: barrier function and injury. Laboratory Investigation; A Journal of Technical Methods and Pathology 79:1181–1199
Baue AE (1992) The horror autotoxicus and multiple-organ failure. Arch Surg 127:1451–1462
Bednarik J, Lukas Z, Vondracek P (2003) Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29:1505–1514
Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. Journal of Neurology 252:343–351
Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W (1992) Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrobial Agents and Chemotherapy 36:2139–2146
Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ (1996) Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 22:849–855
Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA, Jr. (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. The Journal of Clinical Investigation 76:2003–2011
Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle and Nerve 32:140–163
Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Critical Care Medicine 24:1408–1416
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ (1984) Polyneuropathy in critically ill patients. Journal of Neurology, Neurosurgery, and Psychiatry 47:1223–1231
Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ (1986) Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 49:563–573
Bolton CF, Young GB, Zochodne DW (1993) The neurological complications of sepsis. Annals of Neurology 33:94–100
Cankayali I, Dogan YH, Solak I, Demirag K, Eris O, Demirgoren S, Moral AR (2007) Neuromuscular deterioration in the early stage of sepsis in rats. Crit Care 11:R1
Coakley JH, Nagendran K, Honavar M, Hinds CJ (1993) Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 19:323–328
Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ (1998) Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 24:801–807
Coronel B, Mercatello A, Couturier JC, Durand PG, Holzapfell L, Blanc PL, Robert D (1990) Polyneuropathy: potential cause of difficult weaning. Critical Care Medicine 18:486–489
de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Critical Care Medicine 29:2281–2286
Druschky A, Herkert M, Radespiel- Troger M, Druschky K, Hund E, Becker CM, Hilz MJ, Erbguth F, Neundorfer B (2001) Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 27:686–693
Fenzi F, Latronico N, Refatti N, Rizzuto N (2003) Enhanced expression of Eselectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathologica 106:75–82
Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano- Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288–1296
Gorson KC, Ropper AH (1993) Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy. Critical Care Medicine 21:267–271
Hinshaw LB (1996) Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Critical Care Medicine 24:1072–1078
Hund E (2001) Critical illness polyneuropathy. Current Opinion in Neurology 14:649–653
Hund E, Genzwurker H, Bohrer H, Jakob H, Thiele R, Hacke W (1997) Predominant involvement of motor fibres in patients with critical illness polyneuropathy. British Journal of Anaesthesia 78:274–278
Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W (1996) Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Critical Care Medicine 24:1328–1333
Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, Bera P, Luciani D, Nardella A, Vittorielli E, Simini B, Candiani A (2007) Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care 11:R11
Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582
Latronico N, Peli E, Botteri M (2005) Critical illness myopathy and neuropathy. Current Opinion in Critical Care 11:126–132
Latronico N, Shehu I, Seghelini E (2005) Neuromuscular sequelae of critical illness. Current Opinion in Critical Care 11:381–390
Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW (1995) The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274:1221–1225
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31:1250–1256
Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gramnegative sepsis. Intensive Care Med 23:1144–1149
Nates JL, Cooper DJ, Day B, Tuxen DV (1997) Acute weakness syndromes in critically ill patients–a reappraisal. Anaesthesia and Intensive Care 25:502–513
Op de Coul AA, Verheul GA, Leyten AC, Schellens RL, Teepen JL (1991) Critical illness polyneuromyopathy after artificial respiration. Clinical Neurology and Neurosurgery 93:27–33
Pilz G, Appel R, Kreuzer E, Werdan K (1997) Comparison of early IgMenriched immunoglobulin vs polyvalent IgG administration in scoreidentified postcardiac surgical patients at high risk for sepsis. Chest 111:419–426
Pober JS (1988) Warner-Lambert/ Parke-Davis award lecture. Cytokinemediated activation of vascular endothelium. Physiology and pathology. The American Journal of Pathology 133:426–433
Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893–1896
Poynton CH, Jackson S, Fegan C, Barnes RA, Whittaker JA (1992) Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplantation 9:451–457
Sander HW, Golden M, Danon MJ (2002) Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle and Nerve 26:499–505
Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Critical Care Medicine 19:1104–1113
Schwarz J, Planck J, Briegel J, Straube A (1997) Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle and Nerve 20:696–701
Souron V, Chollet S, Ordronneau JR, Chailleux E (1995) Secondary neuromuscular deficiencies in critical care patients. Annales françaises d’anesthesie et de réanimation 14:213–217
Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360–1363
Tepper M, Rakic S, Haas JA, Woittiez AJ (2000) Incidence and onset of critical illness polyneuropathy in patients with septic shock. The Netherlands Journal of Medicine 56:211–214
Trunkey DD (1988) Inflammation and trauma. Arch Surg 123:1517
Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, Sibbald WJ (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176–184
Zifko UA (2000) Long-term outcome of critical illness polyneuropathy. Muscle and nerve 9:S49–S52
Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA (1987) Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110 (Pt 4):819–841
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohammadi, B., Schedel, I., Graf, K. et al. Role of endotoxin in the pathogenesis of critical illness polyneuropathy. J Neurol 255, 265–272 (2008). https://doi.org/10.1007/s00415-008-0722-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0722-0